Leaflet: information for the user
Dexamethasone TAD 20 mg tablets
Dexamethasone TAD 40 mg tablets
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Dexametasona TAD is a synthetic glucocorticoid. Glucocorticoids are hormones produced by the cortex of the adrenal glands. This medication has anti-inflammatory, analgesic, and antiallergic effects, and suppresses the immune system.
Dexametasona TAD is recommended for the treatment of rheumatic and autoimmune diseases (e.g., myositis), skin diseases (e.g., pemphigus vulgaris), blood diseases (e.g., idiopathic thrombocytopenic purpura in adults), treatment of multiple myeloma, symptomatic leukaemia, acute lymphoblastic leukaemia, Hodgkin's disease, and non-Hodgkin lymphoma in conjunction with other medications,metastatic spinal cord compression (pressure on the spinal cord nerves caused by a tumor),prophylaxis and treatment of nausea and vomiting caused by chemotherapy, within the antiemetic treatment.
Do not takeDexamethasone TAD:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dexamethasone TAD:
Problems with the mind may occur while taking steroids like Dexamethasone TAD:
Consult your doctor if you are taking (or someone taking this medication), show signs of mental problems.
This is especially important if you are depressed, or you may be thinking about suicide. In a few cases, mental problems have occurred when doses were reduced or stopped.
Consult your doctor before starting to take this medication:
Treatment with this medication may cause a pheochromocytoma crisis, which can be fatal. Pheochromocytoma is a rare tumor of the adrenal glands. The crisis may have the following symptoms: headaches, sweating, palpitations, and hypertension. Contact your doctor immediately if you experience any of these symptoms.
Treatment with corticosteroids may reduce your body's ability to fight infections. This can lead to infections caused by germs that rarely cause infection in normal circumstances (called opportunistic infections). If you have any type of infection during treatment with this medication, contact your doctor immediately. This is especially important if you notice signs of pneumonia: cough, fever, difficulty breathing, and chest pain. You may also feel confused, especially if you are an elderly patient. You should also inform your doctor if you have had tuberculosis or if you have been in regions where intestinal worm infections are common.
It is essential to avoid contact with someone who has had chickenpox, shingles, or measles while taking this medication. If you think you may have been exposed to any of these diseases, you should consult your doctor immediately. You should also inform your doctor if you have ever had infectious diseases such as measles or chickenpox and if you have been vaccinated.
Contact your doctor if you experience symptoms of tumor lysis syndrome such as muscle cramps, muscle weakness, confusion, vision loss or alteration, and difficulty breathing, if you have a malignant hematological process.
Contact your doctor if you experience blurred vision or other visual disturbances.
Treatment with this medication may cause central serous chorioretinopathy, an eye disorder that causes blurred or distorted vision. This usually occurs in one of the two eyes. Treatment with this medication may cause tendon inflammation. In extremely rare cases, the tendon may rupture. This risk is increased with certain antibiotics and kidney problems. Contact your doctor if you experience pain, swollen or stiff joints, or tendons.
Treatment with Dexamethasone TAD may cause a condition called adrenal insufficiency. This may cause a change in the effectiveness of the medication after stress and trauma, surgery, childbirth, or illness, and your body may not be able to respond normally to severe stress, such as accidents, surgery, childbirth, or illness.
If you have had an accident, are ill, have any specific physical stress situation, or require any surgery (even dental) or are to be vaccinated (particularly with live vaccines) while taking or having finished taking dexamethasone, you must inform the person treating you that you are taking or have taken steroids.
If you need to have suppression tests (tests for hormone levels in the body), skin allergy tests, or bacterial infection tests, you must inform the person performing the test that you are taking dexamethasone, as it may interfere with the results.
Your doctor may reduce the amount of salt in your diet and give you potassium supplements while taking this medication.
If you are an elderly patient, some of the side effects of this medication may be more severe, especially bone thinning (osteoporosis), high blood pressure, low potassium levels, diabetes, and susceptibility to infections and skin thinning. Your doctor will monitor you more closely.
Children
If a child is taking this medication, it is essential that your doctor monitor their growth and development at frequent intervals.Dexamethasone TAD should not be used routinely in premature infants with respiratory problems.
Other medications and Dexamethasone TAD
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication:
Inform your doctor if you are taking or have taken recently other medications, even those purchased without a prescription. You may have an increased risk of severe side effects if you take dexamethasone with these medications
You should read the prospectus of all medications you take with Dexamethasone TAD, regarding the information of these medications before starting treatment with Dexamethasone TAD. When using talidomida, lenalidomida, or pomalidomida, special attention should be paid to pregnancy tests and prevention needs.
Dexamethasone TAD with food, drinks, and alcohol
Dexamethasone should be taken with or after food to minimize gastrointestinal irritation. Avoid drinks containing alcohol or caffeine. It is recommended to take small, frequent meals, and the possibility of taking anti-acids, if recommended by your doctor.
Pregnancy and lactation
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication.
Dexamethasone TAD should only be prescribed during pregnancy and particularly in the first trimester, if the benefits outweigh the risks for the mother and the child. If you become pregnant while taking the medication, do not stop taking Dexamethasone TAD, but inform your doctor immediately that you are pregnant. Corticosteroids can pass into breast milk. The risk cannot be ruled out in newborns/babies. The decision to continue or discontinue breastfeeding or continue or discontinue dexamethasone treatment should be made considering the benefit of breastfeeding for the child and the benefit of dexamethasone treatment for the woman.
Driving and operating machines
Do not drive, use tools or machines, or perform any hazardous tasks if you experience side effects such as confusion, hallucinations, dizziness, fatigue, sleepiness, fainting, or blurred vision.
Dexamethasone TAD contains lactose
This medication contains lactose. If your doctor has indicated that you have a lactose intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Dexamethasone is presented in the form of tablets of 4 mg, 8 mg, 20 mg, and 40 mg. The tablet can be divided into equal halves to take additional doses of 2 mg and 10 mg or to facilitate swallowing.
Dexamethasone TAD is usually taken at doses of 0.5 to 10 mg per day, depending on the disease being treated.
In more severe diseases, doses above 10 mg per day may be required. The dose should be adjusted according to the individual patient's response and the severity of the disease. To minimize adverse effects, the lowest effective dose should be used.
Unless otherwise indicated, the following dose recommendations apply:
The dose recommendations mentioned below are only orientative.
The initial and daily doses should always be determined based on the individual patient's response and the severity of the disease.
The dose and frequency of administration vary with the therapeutic protocol and associated treatments. Dexamethasone administration should follow the instructions for dexamethasone administration as described in the technical data sheet of the associated treatments. If this is not the case, local or international treatment protocols and guidelines should be followed. Prescribing physicians should carefully evaluate what dose of dexamethasone should be used, taking into account the patient's disease situation and state.
Long-term treatment
For long-term treatment of various diseases, after initial therapy, the treatment with glucocorticoids should be changed from dexamethasone to prednisone/prednisolone to reduce adrenal cortex function suppression.
Use in children
If a child is taking this medication, the doctor should monitor their growth and development at frequent intervals.
If you take more Dexamethasone TAD than you should
If you take too much medication, contact your doctor or hospital immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and leaflet to the healthcare professional.
If you forget to take Dexamethasone TAD
If you forget to take a dose, take it as soon as you remember, unless it is almost time for the next dose.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Dexametasona TAD
If your treatment is to be interrupted, follow your doctor's recommendations. He may recommend that you gradually reduce the amount of medication you are taking gradually until you stop taking it completely. Different symptoms have been reported when treatment is interrupted too quickly, such as low blood pressure and, in some cases, relapse of the disease for which you took the treatment.
You may also experience a "withdrawal syndrome" that includes fever, muscle and joint pain, inflammation of the nasal mucosa (rhinitis), weight loss, itching skin, and eye inflammation (conjunctivitis). If you interrupt treatment too soon and any of the mentioned symptoms appear, talk to your doctor as soon as possible.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Consult your doctor immediately if you experience severe mental health problems. These can affect 5 out of 100 people who take medicines like dexamethasone. These problems include:
Consult your doctor immediately if you experience:
This medicine may worsen existing heart problems. If you experience shortness of breath or swelling of the ankles, consult your doctor immediately.
Other side effects may be (unknown frequency):
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require any special temperature for conservation.
Store in the original packaging to protect it from light and humidity.
Medications should not be thrown down the drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Dexamethasone TAD
Dexamethasone TAD 20 mg tablets
Each tablet contains 20 mg of dexamethasone
Dexamethasone TAD 40 mg tablets
Each tablet contains 40 mg of dexamethasone.
Appearance of the product and contents of the pack
20 mg tablets: White or almost white, round tablets with bevelled edges, scored and marked with a 20 on one face (thickness: 4.0-6.0 mm; diameter: 10.7-11.3 mm). The tablet can be divided into equal doses.
40 mg tablets: White or almost white, oval tablets, scored on both faces (thickness: 6.0-8.0 mm; length: 18.7-19.3 mm). The tablet can be divided into equal doses.
Dexametasona TAD is available in packs containing 10, 20, 30, 50, 60, 100, 10 x 1, 20 x 1, 30 x 1, 50 x 1, 60 x 1 and 100 x 1 tablets in blisters.
Only some pack sizes may be marketed.
Marketing authorisation holder
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
Responsible for manufacturing
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Ó
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
You can request more information about this medicine by contacting the local representative of the marketing authorisation holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicine is authorised in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Hungary:Dexamethasone Krka 20 mg tabletta / Dexamethasone Krka 40 mg tabletta
Bulgaria:???????????????20 mg????????/???????????????40 mg????????
Czech Republic:Dexamethasone Krka 20 mg / Dexamethasone Krka 40 mg
Estonia:Dexamethason Krka
Croatia:Dexamethason Krka 20 mg tablete / Dexamethason Krka 40 mg tablete
Latvia:Dexamethason Krka 20 mg tabletes / Dexamethason Krka 40 mg tabletes
Lithuania:Dexamethasone Krka 20 mg tabletes / Dexamethasone Krka 40 mg tabletes
Poland:Dexamethasone Krka
Romania:Dexametazona Krka 20 mg comprimate / Dexametazona Krka 40 mg comprimate
Slovenia:Dexamethason Krka 20 mg tablete / Dexamethason Krka 40 mg tablete
Slovakia:Dexametazon Krka 20 mg tablety / Dexametazon Krka 40 mg tablety
Germany:Dexamethason TAD 20 mg Tabletten / Dexamethason TAD 40 mg Tabletten
Spain:Dexametasona TAD 20 mg comprimidos / Dexametasona TAD 40 mg comprimidos
United Kingdom:Dexamethasone 20 mg tablets / Dexamethasone 40 mg tablets
Portugal:Dexametasona Krka 20 mg comprimidos/ Dexametasona Krka 40 mg comprimidos
Last update of this leaflet:July 2021
More detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.